BR9307035A - Processo para redução dos níveis sanguíneos de colesterol total e de colesterol de lipoproteína de baixa densidade - Google Patents

Processo para redução dos níveis sanguíneos de colesterol total e de colesterol de lipoproteína de baixa densidade

Info

Publication number
BR9307035A
BR9307035A BR9307035A BR9307035A BR9307035A BR 9307035 A BR9307035 A BR 9307035A BR 9307035 A BR9307035 A BR 9307035A BR 9307035 A BR9307035 A BR 9307035A BR 9307035 A BR9307035 A BR 9307035A
Authority
BR
Brazil
Prior art keywords
cholesterol
low density
density lipoprotein
blood levels
reducing blood
Prior art date
Application number
BR9307035A
Other languages
English (en)
Portuguese (pt)
Inventor
Steven L Nissen
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25484425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9307035(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Publication of BR9307035A publication Critical patent/BR9307035A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR9307035A 1992-09-16 1993-09-15 Processo para redução dos níveis sanguíneos de colesterol total e de colesterol de lipoproteína de baixa densidade BR9307035A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94640492A 1992-09-16 1992-09-16
PCT/US1993/008695 WO1994006417A1 (en) 1992-09-16 1993-09-15 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol

Publications (1)

Publication Number Publication Date
BR9307035A true BR9307035A (pt) 1999-06-29

Family

ID=25484425

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307035A BR9307035A (pt) 1992-09-16 1993-09-15 Processo para redução dos níveis sanguíneos de colesterol total e de colesterol de lipoproteína de baixa densidade

Country Status (12)

Country Link
US (1) US5360613A (enExample)
EP (1) EP0660706B1 (enExample)
JP (1) JP3148243B2 (enExample)
AU (1) AU673002B2 (enExample)
BR (1) BR9307035A (enExample)
CA (1) CA2142314C (enExample)
DE (1) DE69327468T2 (enExample)
ES (1) ES2142353T3 (enExample)
FI (1) FI951218L (enExample)
NO (1) NO951000L (enExample)
NZ (1) NZ256300A (enExample)
WO (1) WO1994006417A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US6103764A (en) * 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
AU2620600A (en) * 1999-01-21 2000-08-07 Steroidogenesis Inhibitors International Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
CN100542525C (zh) * 2001-05-18 2009-09-23 隆萨股份公司 制备3-羟基-3-甲基丁酸钠固体制剂的方法
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040220266A1 (en) * 2002-09-09 2004-11-04 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
US6812249B2 (en) * 2003-03-04 2004-11-02 Sal Abraham Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use
WO2005096846A1 (en) * 2004-03-11 2005-10-20 Wiley Organics, Inc. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
BRPI0620083A2 (pt) 2005-12-19 2011-11-01 Abbott Lab usos de b-hidróxi-b-metilbutirato
US20080200422A1 (en) * 2007-01-09 2008-08-21 Cavener Douglas R Methods for reduction of adipose tissue mass
US9770424B2 (en) 2008-12-09 2017-09-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US11173167B2 (en) 2008-12-09 2021-11-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9259430B2 (en) 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9539224B2 (en) 2008-12-09 2017-01-10 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9707241B2 (en) 2008-12-09 2017-07-18 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
WO2010068696A1 (en) * 2008-12-09 2010-06-17 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US8538727B2 (en) * 2009-07-21 2013-09-17 George S. Cembrowski Method and apparatus for calibration and testing of scientific measurement equipment
US11042605B2 (en) 2009-07-21 2021-06-22 Ccqcc Corp. Method and apparatus for calibration and testing of scientific measurement equipment
EP2461704B1 (en) 2010-01-29 2013-10-09 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
IN2012DN06441A (enExample) 2010-01-29 2015-10-09 Abbott Lab
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
PH12014500198A1 (en) * 2011-07-15 2017-02-10 Nusirt Sciences Inc Compositions and methods for modulating metabolic pathways
BR112014003434A2 (pt) * 2011-08-15 2017-03-01 Abbott Lab processo para produção de hmb e seus sais
WO2013067485A1 (en) 2011-11-03 2013-05-10 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
WO2012140276A2 (en) * 2011-11-17 2012-10-18 Lonza Ltd Process for the preparation of 3-hydroxy-3-methylbutyric acid or its calcium salts
PT3733171T (pt) 2012-09-10 2024-01-31 Metabolic Tech Inc Composições compreendendo hmb e atp, bem como a sua utilização
AU2015237273B2 (en) 2014-03-27 2020-06-18 Roland W. Winterfield Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy
CN108697674B (zh) 2015-09-16 2021-09-14 代谢科技有限公司 用于增强从软组织创伤恢复的β-羟基-β-甲基丁酸(HMB)的组合物和使用β-羟基-β-甲基丁酸(HMB)的方法
US12208073B2 (en) 2015-09-16 2025-01-28 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
KR20180088809A (ko) * 2015-11-19 2018-08-07 가부시키가이샤 오츠카 세이야쿠 코죠 3-히드록시이소발레르산의 1가 양이온염의 결정 및 그 결정의 제조 방법
JP2019506393A (ja) 2016-01-21 2019-03-07 メタボリック・テクノロジーズ，インコーポレーテッド オートファジーおよびリポファジーを調節するためのβ−ヒドロキシ−β−メチルブチレート（ＨＭＢ）の組成物および使用方法
SG11201811493UA (en) 2016-06-24 2019-01-30 Otsuka Pharma Factory Inc Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
PT3528801T (pt) 2016-10-21 2024-10-21 Metabolic Tech Llc Composições e métodos de utilização de beta-hidroxi-beta-metilbutirato (hmb) e probióticos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629449A (en) * 1968-04-22 1971-12-21 Majid Siddiqi Process of combatting hypercholesterolemia
US4760090A (en) * 1986-03-11 1988-07-26 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to cattle and sheep
US4764531A (en) * 1986-03-11 1988-08-16 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to laying chickens
US5087472A (en) * 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US5028440A (en) * 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US4992470A (en) * 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals

Also Published As

Publication number Publication date
DE69327468T2 (de) 2000-05-11
JP3148243B2 (ja) 2001-03-19
JPH08501777A (ja) 1996-02-27
DE69327468D1 (de) 2000-02-03
FI951218A7 (fi) 1995-03-15
FI951218A0 (fi) 1995-03-15
NO951000D0 (no) 1995-03-15
ES2142353T3 (es) 2000-04-16
FI951218L (fi) 1995-03-15
NO951000L (no) 1995-03-15
CA2142314C (en) 1999-06-01
EP0660706A4 (enExample) 1995-07-26
AU673002B2 (en) 1996-10-24
EP0660706A1 (en) 1995-07-05
US5360613A (en) 1994-11-01
WO1994006417A1 (en) 1994-03-31
EP0660706B1 (en) 1999-12-29
CA2142314A1 (en) 1994-03-31
AU4922593A (en) 1994-04-12
NZ256300A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
BR9307035A (pt) Processo para redução dos níveis sanguíneos de colesterol total e de colesterol de lipoproteína de baixa densidade
NO950774D0 (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
BR9700993A (pt) Composição e processo para tratamento tópico de descolorações de pele encontradas abaixo dos olhos composição e processo para tratamento tópico de gordura de pele encontrada abaixo dos olhos
PT850948E (pt) Derivados propiofenona e processo para a preparacao dos mesmos
FI941787A0 (fi) Sähkökirurginen prosessori ja menetelmä sen käyttämiseksi
BR9508906A (pt) Processo e aparelho para executar transações diferidas
BR8907538A (pt) Processo e composicao de tecido para enxertos
ATE251627T1 (de) Verfahren und kristallformen von 2- methylthienobenzodiazepinen
BR9608034A (pt) Copolímeros segmentados de polidiorganossiloxano oligouréia e processo para preparação dos mesmos
BR9508586A (pt) Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica
BR9503033A (pt) Estrutura absorvente; produto absorvente descartável e processo para preparar estrutura absorvente
BR9407353A (pt) Processo contínuo para fabricar fita de fixação para peça de vestuário absorvente descartável e fita de fixação para peça de vestuário absorvente descartável
BR9400475A (pt) Processo de preparação de zeólita modificada e zeólita modificada
BR9704258A (pt) Derivados de substâncias ativas decomponíveis hidroliticamente agentes para tratamento capilar contendo esses derivados e processo para tratamento capilar
FI951190A7 (fi) Menetelmä pranoprofeenin stabilisoimiseksi ja pranoprofeenin stabiili nestemäinen valmiste
FI935936L (fi) Menetelmä ja laitteisto sähkökemiallisten laitteiden jäähtymisen estämiseksi
IT1244032B (it) Emulsioni stabili di perfluoropolieteri e sostanze grasse e processo per la loro preparazione
BR9501678A (pt) Preparação e método para tratamento dos cabelos
BR9600745A (pt) Agentes e processo para o tingimento oxidativo dos cabelos
BR9103362A (pt) Processo e dispositivo para preparacao de salmoura
BR8901135A (pt) Composicao para condicionamento de tecido e processo para tratar tecidos
BR9200378A (pt) Processo para preparacao de suportes de destilacao de tolueno diisocianato reativos e de viscosidade estavel e tolueno diisocianato tendo niveis de cloretos hidrolisaveis reduzidos
BR9305707A (pt) Processo para preparaçao de 3-acilestratrienos e acilbenzenos
BR8705025A (pt) Emulsao de agua-em-oleo contendo amidase e processo de tratamento de uma tal emulsao
FI961029L (fi) Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal